Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-09-25

AUTHORS

Virginie Lemiale, Matthieu Resche-Rigon, Elie Azoulay, Study Group for Respiratory Intensive Care in Malignancies (Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie, GRRR-OH)

ABSTRACT

BackgroundAcute respiratory failure (ARF) remains the leading reason for intensive care unit (ICU) admission of immunocompromised patients. In the most severe cases, high-flow oxygen therapy may fail to ensure adequate gas exchange, and mechanical ventilation (MV) must be used. This scenario is associated with high mortality rates of 40 to 60%, depending on the cause of ARF and type of immune deficiency. The use of non-invasive ventilation (NIV) in this situation has been criticized as potentially delaying the initiation of optimal treatment. In contrast, early NIV used prophylactically in patients with ARF who do not meet the criteria for invasive MV (IMV) may obviate the need for IMV, thereby decreasing the morbidity and mortality rates. We aim to demonstrate that a management strategy including early NIV decreases 28-day mortality rates compared to oxygen therapy alone in immunocompromised patients with ARF.Methods/DesignThis is a multicenter parallel-group randomized controlled trial comparing early NIV to oxygen therapy alone in immunocompromised patients with ARF. All immunocompromised adult patients admitted to admission for ARF are eligible for randomization. Patient with ARF onset more than 72 hours earlier or ARF related to cardiogenic pulmonary edema or hypercapnia, or with a need for immediate endotracheal intubation or other organ failure are not eligible.After inclusion patient are allocated to receive early NIV (intervention arm) or oxygen therapy only (control arm).We plan to enroll 374 patients in 29 ICUs. An interim analysis is planned after the inclusion of 187 patients. The main objective is to demonstrate early NIV increases survival as compared to oxygen therapy alone. Other outcomes include the need of IMV, organ failure evolution, nosocomial infections rate, 6 months survival.DiscussionThis study is expected to demonstrate an improved 28-day survival in immunocompromised patients managed with early NIV.Trial registrationRegistration number: Clinicaltrials.gov NCT01915719. Registered on 26 July 2013. More... »

PAGES

372

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1745-6215-15-372

DOI

http://dx.doi.org/10.1186/1745-6215-15-372

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014490297

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25257210


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunocompromised Host", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Noninvasive Ventilation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxygen Inhalation Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Insufficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lemiale", 
        "givenName": "Virginie", 
        "id": "sg:person.01027707313.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027707313.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de Medicine, Universit\u00e9 Paris-Diderot, Sorbonne Paris-Cit\u00e9, 5 Rue Thomas Mann, 75013, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Biostatistics, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France", 
            "Facult\u00e9 de Medicine, Universit\u00e9 Paris-Diderot, Sorbonne Paris-Cit\u00e9, 5 Rue Thomas Mann, 75013, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Resche-Rigon", 
        "givenName": "Matthieu", 
        "id": "sg:person.01036155166.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de Medicine, Universit\u00e9 Paris-Diderot, Sorbonne Paris-Cit\u00e9, 5 Rue Thomas Mann, 75013, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France", 
            "Facult\u00e9 de Medicine, Universit\u00e9 Paris-Diderot, Sorbonne Paris-Cit\u00e9, 5 Rue Thomas Mann, 75013, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Azoulay", 
        "givenName": "Elie", 
        "id": "sg:person.01352577613.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352577613.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Study Group for Respiratory Intensive Care in Malignancies (Groupe de Recherche en R\u00e9animation Respiratoire du patient d\u2019Onco-H\u00e9matologie, GRRR-OH)", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-008-1320-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046047562", 
          "https://doi.org/10.1007/s00134-008-1320-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc10091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014955704", 
          "https://doi.org/10.1186/cc10091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-005-2836-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043972959", 
          "https://doi.org/10.1007/s00134-005-2836-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-009-1662-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015476195", 
          "https://doi.org/10.1007/s00134-009-1662-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2011.232", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026547708", 
          "https://doi.org/10.1038/bmt.2011.232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-009-1717-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006246186", 
          "https://doi.org/10.1007/s00134-009-1717-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-09-25", 
    "datePublishedReg": "2014-09-25", 
    "description": "BackgroundAcute respiratory failure (ARF) remains the leading reason for intensive care unit (ICU) admission of immunocompromised patients. In the most severe cases, high-flow oxygen therapy may fail to ensure adequate gas exchange, and mechanical ventilation (MV) must be used. This scenario is associated with high mortality rates of 40 to 60%, depending on the cause of ARF and type of immune deficiency. The use of non-invasive ventilation (NIV) in this situation has been criticized as potentially delaying the initiation of optimal treatment. In contrast, early NIV used prophylactically in patients with ARF who do not meet the criteria for invasive MV (IMV) may obviate the need for IMV, thereby decreasing the morbidity and mortality rates. We aim to demonstrate that a management strategy including early NIV decreases 28-day mortality rates compared to oxygen therapy alone in immunocompromised patients with ARF.Methods/DesignThis is a multicenter parallel-group randomized controlled trial comparing early NIV to oxygen therapy alone in immunocompromised patients with ARF. All immunocompromised adult patients admitted to admission for ARF are eligible for randomization. Patient with ARF onset more than 72\u00a0hours earlier or ARF related to cardiogenic pulmonary edema or hypercapnia, or with a need for immediate endotracheal intubation or other organ failure are not eligible.After inclusion patient are allocated to receive early NIV (intervention arm) or oxygen therapy only (control arm).We plan to enroll 374 patients in 29 ICUs. An interim analysis is planned after the inclusion of 187 patients. The main objective is to demonstrate early NIV increases survival as compared to oxygen therapy alone. Other outcomes include the need of IMV, organ failure evolution, nosocomial infections rate, 6\u00a0months survival.DiscussionThis study is expected to demonstrate an improved 28-day survival in immunocompromised patients managed with early NIV.Trial registrationRegistration number: Clinicaltrials.gov NCT01915719. Registered on 26 July 2013.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1745-6215-15-372", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297400", 
        "issn": [
          "1468-6708", 
          "1745-6215"
        ], 
        "name": "Trials", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "early non-invasive ventilation", 
      "non-invasive ventilation", 
      "invasive MV", 
      "mechanical ventilation", 
      "mortality rate", 
      "respiratory failure", 
      "intensive care unit admission", 
      "high-flow oxygen therapy", 
      "causes of ARF", 
      "Methods/designThis", 
      "care unit admission", 
      "invasive mechanical ventilation", 
      "acute respiratory failure", 
      "cardiogenic pulmonary edema", 
      "nosocomial infection rates", 
      "immediate endotracheal intubation", 
      "adequate gas exchange", 
      "high mortality rate", 
      "unit admission", 
      "ARF onset", 
      "adult patients", 
      "months survival", 
      "oxygen therapy", 
      "organ failure", 
      "pulmonary edema", 
      "endotracheal intubation", 
      "optimal treatment", 
      "immune deficiency", 
      "inclusion patients", 
      "severe cases", 
      "interim analysis", 
      "patients", 
      "increases survival", 
      "infection rate", 
      "therapy", 
      "DiscussionThis study", 
      "multicenter", 
      "ventilation", 
      "admission", 
      "survival", 
      "trials", 
      "failure", 
      "gas exchange", 
      "DesignThis", 
      "morbidity", 
      "intubation", 
      "ICU", 
      "edema", 
      "hypercapnia", 
      "ARF", 
      "rate", 
      "outcomes", 
      "treatment", 
      "randomization", 
      "onset", 
      "cause", 
      "management strategies", 
      "deficiency", 
      "hours", 
      "need", 
      "initiation", 
      "criteria", 
      "cases", 
      "study", 
      "protocol", 
      "contrast", 
      "objective", 
      "use", 
      "inclusion", 
      "strategies", 
      "reasons", 
      "types", 
      "main objective", 
      "analysis", 
      "situation", 
      "exchange", 
      "scenarios", 
      "evolution", 
      "failure evolution"
    ], 
    "name": "Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial", 
    "pagination": "372", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014490297"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1745-6215-15-372"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25257210"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1745-6215-15-372", 
      "https://app.dimensions.ai/details/publication/pub.1014490297"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_645.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1745-6215-15-372"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-372'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-372'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-372'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-372'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      124 URIs      110 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1745-6215-15-372 schema:about N1a2a4081adad4d89a5e5795c177db2e1
2 N3ef524145aac454c91b7d1a6dcb50d4f
3 N460b767b77b74a99a2336d84c87e7cb3
4 N771ba6b6f34b4bd79b6998dc4e9e1060
5 N7f4fee858000467c92a7586769a51fee
6 N809de3dc34954bf5ab8fc6a9e1f72d0b
7 N8b70aa30c6e6489894ac9d741db89bbd
8 Nbde2d00f77d24c15a653d78ea967a636
9 Nc3cc5de618b147819ca6f241269da939
10 Ndaaaf52f06d44beaa824eb4d730dc0d6
11 Ne2bbe88eb0e741989c6ccac0c3b86bc6
12 Ne8655f9e095941599edf8dd755d0bc58
13 Nf3d5f73640834c128e6ef867a7c8d198
14 Nfffa79c861cc4bfeb16dedecd9e97ca3
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N25ae186971a646b6847b2b9b5adcb041
18 schema:citation sg:pub.10.1007/s00134-005-2836-5
19 sg:pub.10.1007/s00134-008-1320-4
20 sg:pub.10.1007/s00134-009-1662-6
21 sg:pub.10.1007/s00134-009-1717-8
22 sg:pub.10.1038/bmt.2011.232
23 sg:pub.10.1186/cc10091
24 schema:datePublished 2014-09-25
25 schema:datePublishedReg 2014-09-25
26 schema:description BackgroundAcute respiratory failure (ARF) remains the leading reason for intensive care unit (ICU) admission of immunocompromised patients. In the most severe cases, high-flow oxygen therapy may fail to ensure adequate gas exchange, and mechanical ventilation (MV) must be used. This scenario is associated with high mortality rates of 40 to 60%, depending on the cause of ARF and type of immune deficiency. The use of non-invasive ventilation (NIV) in this situation has been criticized as potentially delaying the initiation of optimal treatment. In contrast, early NIV used prophylactically in patients with ARF who do not meet the criteria for invasive MV (IMV) may obviate the need for IMV, thereby decreasing the morbidity and mortality rates. We aim to demonstrate that a management strategy including early NIV decreases 28-day mortality rates compared to oxygen therapy alone in immunocompromised patients with ARF.Methods/DesignThis is a multicenter parallel-group randomized controlled trial comparing early NIV to oxygen therapy alone in immunocompromised patients with ARF. All immunocompromised adult patients admitted to admission for ARF are eligible for randomization. Patient with ARF onset more than 72 hours earlier or ARF related to cardiogenic pulmonary edema or hypercapnia, or with a need for immediate endotracheal intubation or other organ failure are not eligible.After inclusion patient are allocated to receive early NIV (intervention arm) or oxygen therapy only (control arm).We plan to enroll 374 patients in 29 ICUs. An interim analysis is planned after the inclusion of 187 patients. The main objective is to demonstrate early NIV increases survival as compared to oxygen therapy alone. Other outcomes include the need of IMV, organ failure evolution, nosocomial infections rate, 6 months survival.DiscussionThis study is expected to demonstrate an improved 28-day survival in immunocompromised patients managed with early NIV.Trial registrationRegistration number: Clinicaltrials.gov NCT01915719. Registered on 26 July 2013.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf N7364290ad89d4db4b0a1de104714fe4f
30 N749ee654ab73444e88ec5b1f3dab5451
31 sg:journal.1297400
32 schema:keywords ARF
33 ARF onset
34 DesignThis
35 DiscussionThis study
36 ICU
37 Methods/designThis
38 acute respiratory failure
39 adequate gas exchange
40 admission
41 adult patients
42 analysis
43 cardiogenic pulmonary edema
44 care unit admission
45 cases
46 cause
47 causes of ARF
48 contrast
49 criteria
50 deficiency
51 early non-invasive ventilation
52 edema
53 endotracheal intubation
54 evolution
55 exchange
56 failure
57 failure evolution
58 gas exchange
59 high mortality rate
60 high-flow oxygen therapy
61 hours
62 hypercapnia
63 immediate endotracheal intubation
64 immune deficiency
65 inclusion
66 inclusion patients
67 increases survival
68 infection rate
69 initiation
70 intensive care unit admission
71 interim analysis
72 intubation
73 invasive MV
74 invasive mechanical ventilation
75 main objective
76 management strategies
77 mechanical ventilation
78 months survival
79 morbidity
80 mortality rate
81 multicenter
82 need
83 non-invasive ventilation
84 nosocomial infection rates
85 objective
86 onset
87 optimal treatment
88 organ failure
89 outcomes
90 oxygen therapy
91 patients
92 protocol
93 pulmonary edema
94 randomization
95 rate
96 reasons
97 respiratory failure
98 scenarios
99 severe cases
100 situation
101 strategies
102 study
103 survival
104 therapy
105 treatment
106 trials
107 types
108 unit admission
109 use
110 ventilation
111 schema:name Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial
112 schema:pagination 372
113 schema:productId N7843401a4db44d3cb91a74d7eb33baef
114 N93e486d18cff423e95d764c8bd88bc39
115 Naacb5aa1e0c545d6941593f766e2258d
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014490297
117 https://doi.org/10.1186/1745-6215-15-372
118 schema:sdDatePublished 2022-12-01T06:32
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher Nf0dbf89e1aa74d1ab9f85e0cf503e67d
121 schema:url https://doi.org/10.1186/1745-6215-15-372
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N1a2a4081adad4d89a5e5795c177db2e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N1b4970194ac646bc890d19a307c43dfd rdf:first sg:person.01352577613.57
129 rdf:rest Nb769ad2a7d3941ce91d80f8cc91b3957
130 N25ae186971a646b6847b2b9b5adcb041 rdf:first sg:person.01027707313.46
131 rdf:rest Na5a313a170274b0985d26de0be1972f6
132 N3ef524145aac454c91b7d1a6dcb50d4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Immunocompromised Host
134 rdf:type schema:DefinedTerm
135 N460b767b77b74a99a2336d84c87e7cb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Noninvasive Ventilation
137 rdf:type schema:DefinedTerm
138 N7364290ad89d4db4b0a1de104714fe4f schema:issueNumber 1
139 rdf:type schema:PublicationIssue
140 N749ee654ab73444e88ec5b1f3dab5451 schema:volumeNumber 15
141 rdf:type schema:PublicationVolume
142 N771ba6b6f34b4bd79b6998dc4e9e1060 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name France
144 rdf:type schema:DefinedTerm
145 N7843401a4db44d3cb91a74d7eb33baef schema:name doi
146 schema:value 10.1186/1745-6215-15-372
147 rdf:type schema:PropertyValue
148 N7f4fee858000467c92a7586769a51fee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Intensive Care Units
150 rdf:type schema:DefinedTerm
151 N809de3dc34954bf5ab8fc6a9e1f72d0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Respiratory Insufficiency
153 rdf:type schema:DefinedTerm
154 N8b70aa30c6e6489894ac9d741db89bbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Clinical Protocols
156 rdf:type schema:DefinedTerm
157 N93e486d18cff423e95d764c8bd88bc39 schema:name dimensions_id
158 schema:value pub.1014490297
159 rdf:type schema:PropertyValue
160 Na5a313a170274b0985d26de0be1972f6 rdf:first sg:person.01036155166.50
161 rdf:rest N1b4970194ac646bc890d19a307c43dfd
162 Naacb5aa1e0c545d6941593f766e2258d schema:name pubmed_id
163 schema:value 25257210
164 rdf:type schema:PropertyValue
165 Nabc2a4826209410b8f989a223d6ca214 schema:affiliation grid-institutes:grid.413328.f
166 schema:familyName Study Group for Respiratory Intensive Care in Malignancies (Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie, GRRR-OH)
167 rdf:type schema:Person
168 Nb769ad2a7d3941ce91d80f8cc91b3957 rdf:first Nabc2a4826209410b8f989a223d6ca214
169 rdf:rest rdf:nil
170 Nbde2d00f77d24c15a653d78ea967a636 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Time Factors
172 rdf:type schema:DefinedTerm
173 Nc3cc5de618b147819ca6f241269da939 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Acute Disease
175 rdf:type schema:DefinedTerm
176 Ndaaaf52f06d44beaa824eb4d730dc0d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Oxygen Inhalation Therapy
178 rdf:type schema:DefinedTerm
179 Ne2bbe88eb0e741989c6ccac0c3b86bc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Treatment Outcome
181 rdf:type schema:DefinedTerm
182 Ne8655f9e095941599edf8dd755d0bc58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Research Design
184 rdf:type schema:DefinedTerm
185 Nf0dbf89e1aa74d1ab9f85e0cf503e67d schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 Nf3d5f73640834c128e6ef867a7c8d198 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Prospective Studies
189 rdf:type schema:DefinedTerm
190 Nfffa79c861cc4bfeb16dedecd9e97ca3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Risk Factors
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
197 schema:name Clinical Sciences
198 rdf:type schema:DefinedTerm
199 sg:journal.1297400 schema:issn 1468-6708
200 1745-6215
201 schema:name Trials
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01027707313.46 schema:affiliation grid-institutes:grid.413328.f
205 schema:familyName Lemiale
206 schema:givenName Virginie
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027707313.46
208 rdf:type schema:Person
209 sg:person.01036155166.50 schema:affiliation grid-institutes:grid.508487.6
210 schema:familyName Resche-Rigon
211 schema:givenName Matthieu
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50
213 rdf:type schema:Person
214 sg:person.01352577613.57 schema:affiliation grid-institutes:grid.508487.6
215 schema:familyName Azoulay
216 schema:givenName Elie
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352577613.57
218 rdf:type schema:Person
219 sg:pub.10.1007/s00134-005-2836-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043972959
220 https://doi.org/10.1007/s00134-005-2836-5
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s00134-008-1320-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046047562
223 https://doi.org/10.1007/s00134-008-1320-4
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s00134-009-1662-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015476195
226 https://doi.org/10.1007/s00134-009-1662-6
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s00134-009-1717-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006246186
229 https://doi.org/10.1007/s00134-009-1717-8
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/bmt.2011.232 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026547708
232 https://doi.org/10.1038/bmt.2011.232
233 rdf:type schema:CreativeWork
234 sg:pub.10.1186/cc10091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014955704
235 https://doi.org/10.1186/cc10091
236 rdf:type schema:CreativeWork
237 grid-institutes:grid.413328.f schema:alternateName Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France
238 schema:name Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France
239 rdf:type schema:Organization
240 grid-institutes:grid.508487.6 schema:alternateName Faculté de Medicine, Université Paris-Diderot, Sorbonne Paris-Cité, 5 Rue Thomas Mann, 75013, Paris, France
241 schema:name Department of Biostatistics, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France
242 Faculté de Medicine, Université Paris-Diderot, Sorbonne Paris-Cité, 5 Rue Thomas Mann, 75013, Paris, France
243 Medical ICU, Assistance Publique Hopitaux de Paris, St Louis Hospital, 1 avenue Claude Vellefaux, 75010, Paris, France
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...